Literature DB >> 10499548

17Beta-estradiol modulates gastroduodenal preneoplastic alterations in rats exposed to the carcinogen N-methyl-N'-nitro-nitrosoguanidine.

M Campbell-Thompson1, G Y Lauwers, K K Reyher, J Cromwell, K T Shiverick.   

Abstract

Gastric cancers are a significant cause of morbidity worldwide. Epidemiological studies and animal models show that males have higher incidences of gastric cancers compared with females, suggesting that sex hormones may modulate gastric cancer risk. An animal model of the initiation phase of gastric cancer was used to determine the effects of systemic estrogen administration on morphological progression of preneoplastic lesions and to define cell populations at which estrogens may act. Preneoplastic progression in antral and duodenal mucosa was examined in male rats that received the chemical carcinogen, N-methyl-N'-nitro-nitrosoguanidine (MNNG), during treatment with implants containing 17beta-estradiol or oil vehicle. Histopathological changes in antral and duodenal gland morphology, numbers of proliferating cells and apoptotic bodies, and antral gastrin cell numbers and protein storage levels were determined 4 weeks later. With MNNG treatment, duodenal villous heights were significantly decreased, and epithelial cells displayed histological features of hyperplasia and dysplasia. Antral glands showed epithelial hyperplasia and dysplasia, increased mucosal height, and decreased mucin levels. Antral gastrin storage protein levels were decreased by MNNG. Systemic treatment with 17beta-estradiol significantly reversed MNNG-induced alterations in duodenal gland heights while increasing mucin and gastrin levels in antral glands. Cell proliferation and apoptosis rates were not significantly different between groups. The present results indicate that systemic 17beta-estradiol treatment influences antral and duodenal gland differentiation during the initiation phase of chemical gastroduodenal carcinogenesis in male rats. These results explain, in part, a potential pathway through which protective effects of estrogens on chemical carcinogenesis are mediated in the upper gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10499548     DOI: 10.1210/endo.140.10.7030

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  Transretinoic acid inhibits rats gastric epithelial dysplasia induced by N-methyl-N-nitro-N-nitrosoguanidine: influences on cell apoptosis and expression of its regulatory genes.

Authors:  R T Cui; G Cai; Z B Yin; Y Cheng; Q H Yang; T Tian
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  Estrogen and progesterone receptor isoforms expression in the stomach of Mongolian gerbils.

Authors:  Milena Saqui-Salces; Teresa Neri-Gomez; Armando Gamboa-Dominguez; Guillermo Ruiz-Palacios; Ignacio Camacho-Arroyo
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

3.  17 β-estradiol suppresses Helicobacter pylori-induced gastric pathology in male hypergastrinemic INS-GAS mice.

Authors:  Masahiro Ohtani; Zhongming Ge; Alexis García; Arlin B Rogers; Sureshkumar Muthupalani; Nancy S Taylor; Shilu Xu; Koichiro Watanabe; Yan Feng; Robert P Marini; Mark T Whary; Timothy C Wang; James G Fox
Journal:  Carcinogenesis       Date:  2011-05-11       Impact factor: 4.944

Review 4.  Reproductive factors and risk of esophageal squamous cell carcinoma in northern Iran: a case-control study in a high-risk area and literature review.

Authors:  Farhad Islami; Yin Cao; Farin Kamangar; Dariush Nasrollahzadeh; Haji-Amin Marjani; Ramin Shakeri; Saman Fahimi; Masoud Sotoudeh; Sanford M Dawsey; Christian C Abnet; Paolo Boffetta; Reza Malekzadeh
Journal:  Eur J Cancer Prev       Date:  2013-09       Impact factor: 2.497

Review 5.  Gender difference in gastro-esophageal reflux diseases.

Authors:  Kiyotaka Asanuma; Katsunori Iijima; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2016-02-07       Impact factor: 5.742

6.  Sex-associated difference in estrogen receptor β expression in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric cancers in rats.

Authors:  Shin Wakui; Masaya Motohashi; Tomoko Muto; Hiroyuki Takahashi; Hiroshi Hano; Promsuk Jutabha; Naohiko Anzai; Michael F Wempe; Hitoshi Endou
Journal:  Comp Med       Date:  2011-10       Impact factor: 0.982

7.  Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc(Min/+) mice.

Authors:  Alicia G Cleveland; Seija I Oikarinen; Kimberly K Bynoté; Maija Marttinen; Joseph J Rafter; Jan-Ake Gustafsson; Shyamal K Roy; Henry C Pitot; Kenneth S Korach; Dennis B Lubahn; Marja Mutanen; Karen A Gould
Journal:  Carcinogenesis       Date:  2009-06-11       Impact factor: 4.944

8.  THE PROTECTIVE ROLE OF ESTRADIOL & PROGESTERONE IN MALE RATS, FOLLOWING GASTRIC ISCHEMIA-REPERFUSION.

Authors:  Z Keshavarzi; R Mohebbati; N Mohammadzadeh; V Alikhani
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jan-Mar       Impact factor: 0.877

9.  Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas.

Authors:  M Lindblad; L A García Rodríguez; E Chandanos; J Lagergren
Journal:  Br J Cancer       Date:  2006-01-16       Impact factor: 7.640

Review 10.  Sexual dimorphism in bacterial infections.

Authors:  Edgar Ricardo Vázquez-Martínez; Elizabeth García-Gómez; Ignacio Camacho-Arroyo; Bertha González-Pedrajo
Journal:  Biol Sex Differ       Date:  2018-06-20       Impact factor: 5.027

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.